Your browser doesn't support javascript.
loading
Single-molecule characterization of salivary protein aggregates from Parkinson's disease patients: a pilot study.
Furlepa, Martin; Zhang, Yu P; Lobanova, Evgeniia; Kahanawita, Lakmini; Vivacqua, Giorgio; Williams-Gray, Caroline H; Klenerman, David.
Afiliación
  • Furlepa M; Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Zhang YP; Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0PY, UK.
  • Lobanova E; Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Kahanawita L; UK Dementia Research Institute at Cambridge, Cambridge CB2 0XY, UK.
  • Vivacqua G; Department of Chemistry, University of Cambridge, Cambridge CB2 1EW, UK.
  • Williams-Gray CH; UK Dementia Research Institute at Cambridge, Cambridge CB2 0XY, UK.
  • Klenerman D; Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0PY, UK.
Brain Commun ; 6(3): fcae178, 2024.
Article en En | MEDLINE | ID: mdl-38863577
ABSTRACT
Saliva is a convenient and accessible biofluid that has potential as a future diagnostic tool for Parkinson's disease. Candidate diagnostic tests for Parkinson's disease to date have predominantly focused on measurements of α-synuclein in CSF, but there is a need for accurate tests utilizing more easily accessible sample types. Prior studies utilizing saliva have used bulk measurements of salivary α-synuclein to provide diagnostic insight. Aggregate structure may influence the contribution of α-synuclein to disease pathology. Single-molecule approaches can characterize the structure of individual aggregates present in the biofluid and may, therefore, provide greater insight than bulk measurements. We have employed an antibody-based single-molecule pulldown assay to quantify salivary α-synuclein and amyloidpeptide aggregate numbers and subsequently super-resolved captured aggregates using direct Stochastic Optical Reconstruction Microscopy to describe their morphological features. We show that the salivary α-synuclein aggregate/amyloid-ß aggregate ratio is increased almost 2-fold in patients with Parkinson's disease (n = 20) compared with controls (n = 20, P < 0.05). Morphological information also provides insight, with saliva from patients with Parkinson's disease containing a greater proportion of larger and more fibrillar amyloid-ß aggregates than control saliva (P < 0.05). Furthermore, the combination of count and morphology data provides greater diagnostic value than either measure alone, distinguishing between patients with Parkinson's disease (n = 17) and controls (n = 18) with a high degree of accuracy (area under the curve = 0.87, P < 0.001) and a larger dynamic range. We, therefore, demonstrate for the first time the application of highly sensitive single-molecule imaging techniques to saliva. In addition, we show that aggregates present within saliva retain relevant structural information, further expanding the potential utility of saliva-based diagnostic methods.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Brain Commun Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Brain Commun Año: 2024 Tipo del documento: Article Pais de publicación: Reino Unido